Non-invasive Neurally Adjusted Ventilator Assist or Continuous Positive Airway Pressure in Preterm Infants
Primary Purpose
Premature Birth, Respiratory Distress Syndrome, Newborn
Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
CPAP
NIV NAVA
Sponsored by
About this trial
This is an interventional treatment trial for Premature Birth focused on measuring Infants, preterm, Respiration, Artificial, Diaphragm, Intensive Care Units, Neonatal, Continuous Positive Airway Pressure, Non invasive neurally adjusted ventilator assist
Eligibility Criteria
Inclusion Criteria:
- spontaneously breathing preterm infants 24 to 96 hours old
- gestational age (GA) between week 28+0 and 31+6
- preterm infants with GA < 28+0 with a postmenstrual age (PMA) > 28 weeks
- at least 72 hours old treated with CPAP or NIV NAVA
Exclusion Criteria:
- preterm infants with severe congenital malformation
- need for vasopressors
- preterm children in need of a specific respiratory support system due to medical reasons
Sites / Locations
- Department of Pediatrics St Olavs Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
CPAP
respiratory stressed infants getting NIV NAVA
Arm Description
respiratory stressed infants getting Continuous positive airway pressure (CPAP)
respiratory stressed infants getting Non-invasive neurally adjusted ventilatory assist (NIV NAVA)
Outcomes
Primary Outcome Measures
Electrical activity of the diaphragm
Electromyography signals from the diaphragm in 30 second intervals
Secondary Outcome Measures
Silverman Andersen Respiratory Severity Score
The scoring tool consists of 5 categories and respiratory distress are graded from zero to two for each category. Respiratory distress gets worse the higher the total score gets.
Scoring blinded for the intervention
During each intervention, the infants will be video recorded for a blinded assessment.
COMFORTneo pain scale
Measuring pain and discomfort in a seven category scale graded from 1 - 5, where one is best and five is worse.
Parents opinion about the outcomes
Three questions about their opinion about the interventions in a 5 point Likert scale
Respiratory rate
Standard monitoring on IntelliVue monitor
Heart rate
Standard monitoring on IntelliVue monitor
Oxygen saturation
Standard monitoring on IntelliVue monitor
number of apneic episodes ≥ 20 seconds
Using trend function on the IntelliVue monitor
Full Information
NCT ID
NCT04333563
First Posted
April 1, 2020
Last Updated
July 13, 2022
Sponsor
St. Olavs Hospital
Collaborators
Norwegian University of Science and Technology
1. Study Identification
Unique Protocol Identification Number
NCT04333563
Brief Title
Non-invasive Neurally Adjusted Ventilator Assist or Continuous Positive Airway Pressure in Preterm Infants
Official Title
Non-invasive Neurally Adjusted Ventilator Assist or Continuous Positive Airway Pressure in Preterm Infants: A Randomized Crossover Study
Study Type
Interventional
2. Study Status
Record Verification Date
July 2022
Overall Recruitment Status
Completed
Study Start Date
April 14, 2020 (Actual)
Primary Completion Date
April 30, 2022 (Actual)
Study Completion Date
April 30, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
St. Olavs Hospital
Collaborators
Norwegian University of Science and Technology
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Strategies to prevent lung injury, facilitate lung development, and to support the preterm infant's capacity to breathe are decisive. Continuous positive airway pressure (CPAP) is the gold standard in non-invasive breathing support in preterm infants with a positive pressure that keeps the alveoli slightly inflated during expiration. Non-invasive neurally adjusted ventilator assist (NIV NAVA) is a novel method of breathing support and uses the electrical activity from the diaphragm to trigger the ventilator and synchronize with the breathing cycle. During NIV NAVA the preterm infant controls the onset of the inspiration, the respiratory rate, inspiratory time and peak pressure. This method has the potential to improve the positive pressure transmission to the infant's lower airways, accurate synchronization with the breathing pattern and be a comfortable breathing support system for the preterm infant.
The investigators will compare the effect on breathing effort in preterm infants during continuous positive airway pressure and non-invasive neurally adjusted ventilatory assist measured by electrical activity in the diaphragm, respiratory vital signs, systematic clinical scoring of breathing effort and comfort, and parent reported outcomes.
Detailed Description
This is a randomized cross-over study with AB/BA sequences. The infants will receive both interventions in 4 hours intervals, a 30 minutes period to change the breathing support and a 30 minutes wash out period between interventions. Initially positive end expiratory pressure are set to 5 cm H2O and can be adjusted up to 7 cm H2O if needed decided by the medical team for both interventions. The neurally adjusted level will be set to obtain average Edi peak < 15 microvolt. Back-up setting and apnea time in the ventilator assist intervention (NIV NAVA) will be individualized according to clinical parameters in each preterm infant.
Modification approved by ethical committee REK 2021, 6th of August:
After two hours in each intervention, the nurse responsible for the infant will perform the clinical scoring. In addition it will be investigated if there is a difference in respiratory vital signs during skin to skin care and in the incubator. During each intervention period, the preterm infants are placed on the parent's chest skin to skin for at least one hour.
A modified version of the scoring tool will be used, i.e. without the item of nasal flaring and expiratory grunting. The headgear for CPAP and NIV NAVA covers parts of the nose and makes nasal flaring difficult to observe.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Premature Birth, Respiratory Distress Syndrome, Newborn
Keywords
Infants, preterm, Respiration, Artificial, Diaphragm, Intensive Care Units, Neonatal, Continuous Positive Airway Pressure, Non invasive neurally adjusted ventilator assist
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Care ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
CPAP
Arm Type
Active Comparator
Arm Description
respiratory stressed infants getting Continuous positive airway pressure (CPAP)
Arm Title
respiratory stressed infants getting NIV NAVA
Arm Type
Experimental
Arm Description
respiratory stressed infants getting Non-invasive neurally adjusted ventilatory assist (NIV NAVA)
Intervention Type
Device
Intervention Name(s)
CPAP
Intervention Description
Continuous positive airway pressure
Intervention Type
Device
Intervention Name(s)
NIV NAVA
Intervention Description
Non-invasive neurally adjusted ventilatory assist
Primary Outcome Measure Information:
Title
Electrical activity of the diaphragm
Description
Electromyography signals from the diaphragm in 30 second intervals
Time Frame
9 hours and 30 minutes
Secondary Outcome Measure Information:
Title
Silverman Andersen Respiratory Severity Score
Description
The scoring tool consists of 5 categories and respiratory distress are graded from zero to two for each category. Respiratory distress gets worse the higher the total score gets.
Time Frame
Three minutes
Title
Scoring blinded for the intervention
Description
During each intervention, the infants will be video recorded for a blinded assessment.
Time Frame
Three minutes video-recording
Title
COMFORTneo pain scale
Description
Measuring pain and discomfort in a seven category scale graded from 1 - 5, where one is best and five is worse.
Time Frame
Three minutes
Title
Parents opinion about the outcomes
Description
Three questions about their opinion about the interventions in a 5 point Likert scale
Time Frame
Three minutes
Title
Respiratory rate
Description
Standard monitoring on IntelliVue monitor
Time Frame
30 second intervals
Title
Heart rate
Description
Standard monitoring on IntelliVue monitor
Time Frame
30 second intervals
Title
Oxygen saturation
Description
Standard monitoring on IntelliVue monitor
Time Frame
30 second intervals
Title
number of apneic episodes ≥ 20 seconds
Description
Using trend function on the IntelliVue monitor
Time Frame
9 hours and 30 seconds
10. Eligibility
Sex
All
Minimum Age & Unit of Time
24 Hours
Maximum Age & Unit of Time
96 Hours
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
spontaneously breathing preterm infants 24 to 96 hours old
gestational age (GA) between week 28+0 and 31+6
preterm infants with GA < 28+0 with a postmenstrual age (PMA) > 28 weeks
at least 72 hours old treated with CPAP or NIV NAVA
Exclusion Criteria:
preterm infants with severe congenital malformation
need for vasopressors
preterm children in need of a specific respiratory support system due to medical reasons
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elisabeth Selvaag, md
Organizational Affiliation
St Olavs Hospital, Barne- og ungdomsklinikk
Official's Role
Study Director
Facility Information:
Facility Name
Department of Pediatrics St Olavs Hospital
City
Trondheim
Country
Norway
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Study protocol Statistical analysis Informed consent form
IPD Sharing Time Frame
2022 and to 2027
IPD Sharing URL
https://hilde.brenne@stolav.no
Learn more about this trial
Non-invasive Neurally Adjusted Ventilator Assist or Continuous Positive Airway Pressure in Preterm Infants
We'll reach out to this number within 24 hrs